4//SEC Filing
BIND Therapeutics, Inc 4
Accession 0001209191-15-085560
CIK 0001385228operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:18 PM ET
Size
5.6 KB
Accession
0001209191-15-085560
Insider Transaction Report
Form 4
YINGLING JONATHAN MICHAEL
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-12-14+200,000→ 200,000 totalExercise: $2.38Exp: 2025-12-13→ COMMON STOCK (200,000 underlying)
Footnotes (1)
- [F1]Beginning on December 14, 2015, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
BIND Therapeutics, Inc
CIK 0001385228
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001385228
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:18 PM ET
- Size
- 5.6 KB